Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics.
A biotechnology pioneer since 1980, Amgen has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.
Sessions sponsored by Amgen
Osteoporosis in primary care
Dr Louise Warburton, Clinical lead for Telford MSK Service